Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Catherine Daniel"'
Autor:
Sophie El Zein, Lounes Djeroudi, Stéphanie Reynaud, Delphine Guillemot, Julien Masliah‐Planchon, Eléonore Frouin, Nayla Nicolas, François Le Loarer, Catherine Daniel, Olivier Delattre, Gaëlle Pierron, Sarah Watson
Publikováno v:
Genes, Chromosomes and Cancer. 61:200-205
Over the last decade, the development of next-generation sequencing techniques has led to the molecular dismantlement of adult and pediatric sarcoma, with the identification of multiple gene fusions associated with specific subtypes and currently int
Autor:
Sophie, Salomé-Desnoulez, Sabine, Poiret, Benoit, Foligné, Ghaffar, Muharram, Véronique, Peucelle, Frank, Lafont, Catherine, Daniel
Publikováno v:
Gut Microbes
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The gastrointestinal tract is the main ecological niche in which Lactobacillus strains may provide health benefits in mammals. There is currently a need to characterize host-microbe interactions in space and time by tracking these bacteria in vivo. W
Autor:
Alexis B. Cortot, David Planchard, Hélène Doubre, Bénédicte Mastroianni, Sylvestre Le Moulec, Florian Guisier, Lionel Falchero, Jennifer Arrondeau, Aldo Renault, Isabelle Monnet, Laurent Greillier, Marie Wislez, L. Gérinière, Jean Bernard Auliac, Chantal Decroisette, Maurice Pérol, Eric Pichon, Catherine Daniel, Christos Chouaid, Roland Schott
Publikováno v:
Lung Cancer
Lung Cancer, 2019, 127, pp.96-102. ⟨10.1016/j.lungcan.2018.11.037⟩
Lung Cancer, Elsevier, 2019, 127, pp.96-102. ⟨10.1016/j.lungcan.2018.11.037⟩
Lung Cancer, 2019, 127, pp.96-102. ⟨10.1016/j.lungcan.2018.11.037⟩
Lung Cancer, Elsevier, 2019, 127, pp.96-102. ⟨10.1016/j.lungcan.2018.11.037⟩
International audience; Objectives The efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer (NSCLC) harboring EGFR T790 M resistance mutation was demonstrated in clinical trials. However, data on efficacy of osimert
Autor:
Anne Garat, Sabine Poiret, Ghaffar Muharram, Catherine Daniel, Annie Standaert, Fanny George, Stéphanie Ferreira, Véronique Peucelle, Hélène Sobry, Anca Lucau-Danila, Benoît Foligné
Publikováno v:
FASEB Journal
FASEB Journal, 2020, 34 (9), pp.12615-12633. ⟨10.1096/fj.202000562rr⟩
FASEB Journal, Federation of American Society of Experimental Biology, 2020, 34 (9), pp.12615-12633. ⟨10.1096/fj.202000562rr⟩
FASEB Journal, 2020, 34 (9), pp.12615-12633. ⟨10.1096/fj.202000562rr⟩
FASEB Journal, Federation of American Society of Experimental Biology, 2020, 34 (9), pp.12615-12633. ⟨10.1096/fj.202000562rr⟩
International audience; Although it is known that zinc has several beneficial roles in the context of gut inflammation, the underlying mechanisms have not been extensively characterized. Zinc (Zn) is known to be the primary physiological inducer of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88153ac77d2933bb94c115d6dfa5199
https://hal.science/hal-03300651
https://hal.science/hal-03300651
Autor:
Chantal Decroisette, Etienne Giroux Leprieur, Olivier Molinier, Elisa Gobbini, Catherine Dubos, Denis Moro-Sibilot, Eric Dansin, Jean-Baptiste Assié, Dahna Coupez, Remi Veillon, Boris Duchemann, Anne Claire Toffart, Valérie Gounant, Nouha Chaabane, Matteo Giaj Levra, Laura Mezquita, François-Roger Vanel, Virginie Westeel, Youssef Oulkhouir, Vincent Alcazer, Michael Duruisseaux, A. Canellas, Fabrice Barlesi, Maurice Pérol, Myriam Delaunay, Florian Guisier, Pierre Fournel, Hélène Babey, Catherine Daniel
Publikováno v:
Clinical lung cancer. 21(5)
Background Immune checkpoint inhibitor (ICPi) rechallenge could represent an attractive option in non–small-cell lung cancer (NSCLC), yet no sufficient data supporting this strategy are available. This retrospective observational multicenter nation
Autor:
Catherine, Daniel, Amélie, Dewitte, Sabine, Poiret, Michaël, Marceau, Michel, Simonet, Laure, Marceau, Guillaume, Descombes, Denise, Boutillier, Nadia, Bennaceur, Sébastien, Bontemps-Gallo, Nadine, Lemaître, Florent, Sebbane
Publikováno v:
Frontiers in Immunology
Yersinioses caused by Yersinia pestis, Yersinia pseudotuberculosis, and Yersinia enterocolitica are significant concerns in human and veterinary health. The link between virulence and the potent LcrV antigen has prompted the latter's selection as a m
Autor:
Sandrine, Loubière, Alexandre, Drezet, Michèle, Beau-Faller, Denis, Moro-Sibilot, Sylvie, Friard, Marie, Wislez, Hélène, Blons, Catherine, Daniel, Virginie, Westeel, Anne, Madroszyk, Hervé, Léna, Patrick, Merle, Julien, Mazières, Gérard, Zalcman, Roger, Lacave, Martine, Antoine, Franck, Morin, Pascale, Missy, Fabrice, Barlesi, Pascal, Auquier, Jacques, Cadranel
Publikováno v:
The European respiratory journal. 51(3)
Autor:
Charlotte Proudhon, Maud Milder, E. Romano, Catherine Daniel, Ivan Bièche, Alain Livartowski, Jean-Yves Pierga, Vincent Servois, Sophie Piperno-Neumann, François-Clément Bidard, Sylvain Baulande, Bruno Buecher, Luc Cabel, Francesca Riva, Aurore Rampanou, Olivier Lantz, Virginie Bernard
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 28(8)
Recent clinical results support the use of new immune checkpoint blockers (ICB), such as anti-PD-1 (e.g. nivolumab and pembrolizumab) and anti-PD-L1 antibodies. Radiological evaluation of ICB efficacy during therapy is challenging due to tumor immune
Autor:
Marie Titecat, Jean-Claude Sirard, Nadine Lemaître, Michel Simonet, Florent Sebbane, Catherine Daniel, Delphine Cayet, Sabine Poiret, Denise Boutillier
Publikováno v:
Vaccine
Vaccine, 2016, 34 (47), pp.5762-5767. ⟨10.1016/j.vaccine.2016.09.060⟩
Vaccine, Elsevier, 2016, 34 (47), pp.5762-5767. ⟨10.1016/j.vaccine.2016.09.060⟩
Vaccine, 2016, 34 (47), pp.5762-5767. ⟨10.1016/j.vaccine.2016.09.060⟩
Vaccine, Elsevier, 2016, 34 (47), pp.5762-5767. ⟨10.1016/j.vaccine.2016.09.060⟩
Background Pseudotuberculosis is an infection caused by the bacterial enteropathogen Yersinia pseudotuberculosis and is considered to be a significant problem in veterinary medicine. We previously found that intranasal administration of a recombinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32a201ca892a37e32e685a57c7939e8
https://www.hal.inserm.fr/inserm-01529277
https://www.hal.inserm.fr/inserm-01529277
Publikováno v:
International Journal of Nursing Studies. 50:1434-1445
Background Patient aggression is a common source of occupational violence in emergency departments. Staff attitudes regarding the causes for aggression influence the way they manage it. The Management of Clinical Aggression – Rapid Emergency Depart